SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001739614-21-000104
Filing Date
2021-10-29
Accepted
2021-10-29 17:28:12
Documents
2
Period of Report
2021-10-28

Document Format Files

Seq Description Document Type Size
1 FORM 3 wf-form3_163554287706319.html 3  
1 FORM 3 wf-form3_163554287706319.xml 3 1718
2 EXHIBIT 24 - POWER OF ATTORNEY FOR KRISTIINA VUORI MD ex-24.htm EX-24 3673
  Complete submission text file 0001739614-21-000104.txt   6785
Mailing Address C/O WEBMD HEALTH CORP. 111 EIGHTH AVENUE NEW YORK NY 10011
Business Address
Vuori Kristiina MD (Reporting) CIK: 0001612627 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-39452 | Film No.: 211364437

Mailing Address 11025 N. TORREY PINES ROAD, SUITE 200 LA JOLLA CA 92037
Business Address 11025 N. TORREY PINES ROAD, SUITE 200 LA JOLLA CA 92037 (858) 795-4220
Inhibrx, Inc. (Issuer) CIK: 0001739614 (see all company filings)

IRS No.: 824257312 | State of Incorp.: CA | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)